MA56520A - Construction de l'interleukine 12 recombinante et ses utilisations - Google Patents

Construction de l'interleukine 12 recombinante et ses utilisations

Info

Publication number
MA56520A
MA56520A MA056520A MA56520A MA56520A MA 56520 A MA56520 A MA 56520A MA 056520 A MA056520 A MA 056520A MA 56520 A MA56520 A MA 56520A MA 56520 A MA56520 A MA 56520A
Authority
MA
Morocco
Prior art keywords
construction
recombinant interleukin
interleukin
recombinant
Prior art date
Application number
MA056520A
Other languages
English (en)
Inventor
Daniel Boden
Pooter Dorien De
Helen Horton
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MA56520A publication Critical patent/MA56520A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA056520A 2019-06-18 2020-06-18 Construction de l'interleukine 12 recombinante et ses utilisations MA56520A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19180939 2019-06-18

Publications (1)

Publication Number Publication Date
MA56520A true MA56520A (fr) 2022-04-27

Family

ID=67060253

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056520A MA56520A (fr) 2019-06-18 2020-06-18 Construction de l'interleukine 12 recombinante et ses utilisations

Country Status (4)

Country Link
EP (1) EP3986915A1 (fr)
CA (1) CA3141323A1 (fr)
MA (1) MA56520A (fr)
WO (1) WO2020255014A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111094330A (zh) 2017-07-03 2020-05-01 转矩医疗股份有限公司 编码免疫刺激融合分子的多核苷酸及其用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA92121A (fr) 1904-11-07 1905-03-14 William Waid Paddock Filtre a pression
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US6041252A (en) 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
ATE337794T1 (de) 1997-04-03 2006-09-15 Electrofect As Verfahren zum verabreichen von pharmazeutischen präparaten und nukleinsäuren an den skelettmuskel
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
US5873849A (en) 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US6117660A (en) 1997-06-10 2000-09-12 Cytopulse Sciences, Inc. Method and apparatus for treating materials with electrical fields having varying orientations
ATE275423T1 (de) 1997-06-30 2004-09-15 Aventis Pharma Sa Verabreichung der nukleinsäure in den quergestreiften muskel
WO2000002621A1 (fr) 1998-07-13 2000-01-20 Genetronics, Inc. Therapie genique par champ electrique pulse visant la peau et les muscles
US6319901B1 (en) 1998-10-15 2001-11-20 Ichor Medical Systems, Inc. Methods for prolonging cell membrane permeability
US7245963B2 (en) 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US8209006B2 (en) 2002-03-07 2012-06-26 Vgx Pharmaceuticals, Inc. Constant current electroporation device and methods of use
US6912417B1 (en) 2002-04-05 2005-06-28 Ichor Medical Systmes, Inc. Method and apparatus for delivery of therapeutic agents
US7328064B2 (en) 2002-07-04 2008-02-05 Inovio As Electroporation device and injection apparatus
EP1648519B1 (fr) 2003-07-16 2014-10-08 Protiva Biotherapeutics Inc. Arn interferant encapsule dans un lipide
EP1729848B1 (fr) 2004-03-08 2015-04-29 Ichor Medical Systems Inc. Appareil ameliore pour une administration electriquement mediee d'agents therapeutiques
AU2005252273B2 (en) 2004-06-07 2011-04-28 Arbutus Biopharma Corporation Lipid encapsulated interfering RNA
PT2066399T (pt) 2006-10-17 2019-01-11 Inovio Pharmaceuticals Inc Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
CN103052400B (zh) 2010-07-06 2016-11-16 诺华股份有限公司 自我复制rna分子的病毒样递送颗粒
GB201013153D0 (en) 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
RU2628705C2 (ru) 2011-08-31 2017-08-21 Новартис Аг Пегилированные липосомы для доставки кодирующей иммуноген рнк
EP2817287B1 (fr) 2012-02-24 2018-10-03 Arbutus Biopharma Corporation Lipides cationiques trialkylés et leurs procédés d'utilisation
GB201502645D0 (en) 2015-02-17 2015-04-01 Touchlight Genetics Ltd Method
JP7072386B2 (ja) 2015-06-29 2022-05-20 アクイタス セラピューティクス インコーポレイテッド 核酸の送達のための脂質および脂質ナノ粒子製剤
CA3001590A1 (fr) * 2015-10-10 2017-04-13 Intrexon Corporation Controle therapeutique ameliore de formes d'interleukine-12 destabilisees sensibles a la proteolyse
ES2938557T3 (es) 2015-10-28 2023-04-12 Acuitas Therapeutics Inc Lípidos y formulaciones de nanopartículas lipídicas novedosos para la entrega de ácidos nucleicos
EP3397613A1 (fr) 2015-12-30 2018-11-07 Acuitas Therapeutics Inc. Lipides et formulations de nanoparticules de lipides pour la libération d'acides nucléiques
US9834510B2 (en) 2015-12-30 2017-12-05 Arcturus Therapeutics, Inc. Aromatic ionizable cationic lipid
MY201757A (en) 2016-03-28 2024-03-15 Ichor Medical Systems Inc Method and apparatus for delivery of therapeutic agents
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
EP3615510B1 (fr) 2017-04-28 2024-03-27 Acuitas Therapeutics, Inc. Nouveaux lipides carbonyles et formulations nanoparticulaires lipidiques pour l'administration d'acides nucléiques
US11639329B2 (en) 2017-08-16 2023-05-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
CA3073018A1 (fr) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. Lipides destines a etre utilises dans des formulations de nanoparticules lipidiques
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations

Also Published As

Publication number Publication date
EP3986915A1 (fr) 2022-04-27
CA3141323A1 (fr) 2020-12-24
WO2020255014A1 (fr) 2020-12-24

Similar Documents

Publication Publication Date Title
MA52426A (fr) Conjugués d'il-15 et leurs utilisations
MA52773A (fr) Anticorps anti-cd3 et leurs utilisations
MA51288A (fr) Analogues d'incrétine et leurs utilisations
IL287273A (en) Recombinant polyclonal proteins and methods of using them
MA51287A (fr) Analogues d'incrétine et leurs utilisations
ZA202106880B (en) Anti-claudin 18.2 antibody and application thereof
MA49512A (fr) Protéines de liaison à l'antigène anti-papillomavirus humain et leurs méthodés d'utilisation
MA54195A (fr) Conjugués d'interleukine 10 et leurs utilisations
SG11202108398YA (en) Anti-claudin 18 antibodies and methods of use thereof
IL275779A (en) Recombinant human sialidases, sialidase-related proteins and methods of using them
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
DK3930847T5 (da) Anti-mertk-antistoffer med høj affinitet og anvendelser deraf
MA49398A (fr) Anticorps monoclonaux anti-igf-1r et utilisations de ceux-ci
MA51753A (fr) Éléments de régulation de la transcription et utilisations associées
MA52190A (fr) Anticorps anti-trem-1 et utilisations associées
MA54955A (fr) Anticorps anti-claudine 6 et leurs utilisations
GB202017058D0 (en) Antibodies and uses thereof
MA52238A (fr) Conjugués de médicament d'agents de liaison monoclonaux cmet, et utilisations associées
IL277007A (en) Therapeutic ANTI-SPLA2-GIB antibodies and their uses
MA54469A (fr) Anticorps anti-il-27 et leurs utilisations
MA56520A (fr) Construction de l'interleukine 12 recombinante et ses utilisations
MA54089A (fr) Anticorps anti-pd-1 humain et procédés d'utilisation associés
IL307267A (en) ANTI-CD122 antibodies and their uses
MA54455A (fr) Anticorps anti-alpha-synucléine et leurs utilisations
MA52485A (fr) Combinaisons de variants d'anticorps et utilisations associées